Goefibro-U Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Ulipristal acetate (5mg)
Overview Goefibro-U Tablet
Uterine fibroids, non-cancerous uterine growths, in premenopausal women unsuitable for or unresponsive to surgery, are treated with the medication Goefibro-U Tablet. This medication alleviates symptoms such as heavy menstrual bleeding, prolonged periods, and lower back pain. Administer as directed, at the same time each day, with or without food, for optimal results. Dosage and duration should strictly follow your physician's instructions. Crucially, Goefibro-U Tablet diminishes the efficacy of birth control; therefore, reliable contraception is essential to prevent pregnancy. Common side effects include the absence of menstruation (amenorrhea), headache, dizziness, fatigue, and nausea. Report any concerning or persistent side effects to your doctor immediately; management strategies may be available. Menstrual bleeding typically ceases within ten days of commencing treatment; however, consult your doctor if heavy bleeding persists. While this medication may temporarily halt menstruation, periods usually resume within four weeks post-treatment. Prior to commencing Goefibro-U Tablet, disclose any history of liver disease or severe asthma to your doctor. Regular liver function blood tests may be conducted during treatment. Complete disclosure of all other medications is vital, as interactions can impact Goefibro-U Tablet's effectiveness or mechanism of action. Finally, inform your doctor if you are pregnant or breastfeeding.
Uses of Goefibro-U Tablet
Benign uterine tumors
Major Benefits of Goefibro-U Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Goefibro-U Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Goefibro-U Tablet:
- Absence of menstrual periods
- Headache
- Endometrial hyperplasia
- Fatigue
- Dizziness
- Nausea
How to use Goefibro-U Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Goefibro-U Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Goefibro-U Tablet works:
Goefibro-U Tablets function as a selective progesterone receptor modulator, altering the effects of the female hormone progesterone. Prescribed pre-operatively for uterine fibroids or intermittently to manage fibroids, it shrinks fibroid size, regulates bleeding, and elevates red blood cell levels.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Goefibro-U Tablet lacks established safety data. Physician consultation is advised.
PregnancyUNSAFE
Using Goefibro-U tablets while pregnant carries substantial risk. Pregnant women should consult their physician; research in both animal and human studies has revealed considerable adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Use of Goefibro-U Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the use of Goefibro-U Tablets, due to potential side effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Goefibro-U Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Goefibro-U Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Goefibro-U Tablet :
Should you forget a Goefibro-U Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Goefibro-U Tablet
| Label | Value |
|---|---|
| Chemical Category | Estradiol-based compound |
| Developing Habits | No. |
| Treatment Category | OBSTETRIC AND GYNECOLOGICAL |


